Ireland· IE-PA-HOR1149/026/001
Ruta grav
A medicinal product containing ruta graveolens, registered in Ireland by A. Nelson & Company Limited.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Ruta graveolens
- Manufacturer
- A. Nelson & Company Limited
- Country
- Ireland (IE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberHOR1149/026/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Ruta graveolens in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a0c17c04-be9d-4aa0-bcdc-bb2b6b32b690 GET /v1/drugs/a0c17c04-be9d-4aa0-bcdc-bb2b6b32b690?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pillules",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": null,
"strength": null,
"pa_number": "HOR1149/026/001",
"substances": [
"Ruta graveolens"
],
"legal_basis": "Not Currently Available",
"market_info": "Not marketed",
"authorised_at": "29/10/2010",
"dispensing_status": "Product not subject to medical prescription",
"registration_status": "AU",
"supply_legal_status": "Supply through non-pharmacy outlets and pharmacies",
"interchangeable_code": null
}See everything about ruta graveolens.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.